Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines

International Journal of Oncology

Volumn 27, Issue 5, 2005, Pages 1345-1353

  Sueoka, Kotaro ^a   Nawata, Shugo ^a   Nakagawa, Tatsushi ^a   Murakami, Akihiro ^a   Takeda, Osamu ^a   Suminami, Yoshinori ^b   Kato, Hiroshi ^c   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sanyo Onoda Municipal Hospital   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Matrix metalloproteinase 9; Serine proteinase inhibitor; Squamous cell carcinoma antigen; Tumor marker

Indexed keywords

MATRIX METALLOPROTEINASE; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL CULTURE; FEMALE; GENETICS; HUMAN; PHENOTYPE; PHYSIOLOGY; PROTEIN CONFORMATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEIN CONFORMATION; SERPINS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 33644648926     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.5.1345     Document Type: Article

References (55)

1. Kato H and Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40: 1621-1628, 1977.
2. Suehiro Y, Kato H, Nagai M and Torigoe T: Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens. Cancer 57: 1380-1384,1986.
3. Kato H, Nagaya T and Torigoe T: Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation. Gann 75: 433-435,1984.
4. Kato H: Squamous cell carcinoma antigen. In: Serological Cancer Markers. Sell S (ed). Humana Press, Clifton, pp437-451, 1992.
5. Duk JM, De Bruijn HWA, Groenier KH, Hollema H, ten Hoor KA, Krans M and Aalders JG: Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determination. Gynecol Oncol 39: 186-194,1990.
6. Duk JM, Klaas H, Groenier KH, De Bruijn HWA, Hollema H, ten Hoor KA, van der Zee AGJ and Aalders JG: Pretreatment of serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol 14:111-118,1996.
7. Bolger BS, Dabbas M, Lopes A and Monaghan JM: Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 65: 309-313, 1997.
8. Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K and Hasumi K: The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol 68: 263-266, 1998.
9. De Bruijin HW, Duk JM, van der Zee AGJ, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, De Vries EG and Aalders JG: The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumor Biol 19: 505-516, 1998.
10. Strauss H-G, Laban C, Lautenschläger C, Buchmann J, Schneider I and Koelbl H: SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur J Cancer 38: 1987-1991,2002.
11. Suminami Y, Kishi F, Sekiguchi K and Kato H: Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181: 51-58, 1991.
12. Kato H: Expression and function of squamous cell carcinoma antigen. Anticancer Res 8: 177-179,1996.
13. Suminami Y, Nawata S and Kato H: Biological role of SCC antigen. Tumor Biol 19: 488-493, 1998.
14. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM and Silverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 92: 3147-3151,1995.
15. Potempa J, Korzus E and Travis J: The serpin superfamily of proteinase inhibitors: structure, function and regulation. J Biol Chem269: 15957-15960, 1994.
16. Silverman GA, Bird PI, Carrel RW, Church FC, Coughlin PB, Gettins PGW, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J and Whisstock JC: The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. J Biol Chem 276:33293-33296,2001.
17. Nawata S, Tsunaga N, Numa F, Tanaka T, Nakamura K and Kato H: Serine protease inhibitor activity of recombinant squamous cell carcinoma antigen towards chymotrypsin, as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Electrophoresis 16: 1027-1030, 1995.
18. Takeda A, Yamamoto T, Nakamura Y, Takahashi T and Hibino T: Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L. FEBS Lett 359: 78-80,1995.
19. Nawata S, Nakamura K, Tanaka T, Numa F, Suminami Y, Tsunaga N, Kakegawa H, Katunuma H and Kato H: Electrophoretic analysis of the 'cross-class' interaction between novel inhibitory serpin, squamous cell carcinoma antigen-1 and cysteine proteases. Electrophoresis 18: 784-789, 1997.
20. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA and Silverman GA: Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 272: 1849-1855, 1997.
21. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, Gornstein ER, Brömme D, Chapman HA and Silverman GA: Cross-class inhibition of the cysteine proteinases cathepsins K, L and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37: 5258-5266, 1998.
22. Sakata Y, Arima K, Takai T, Sakurai W, Masumoto K, Yuyama N, Suminami Y, Kishi F, Yamashita T, Kato T, Ogawa H, Fujimoto K, Matsuo Y, Sugita Y and Izuhara K: The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem 279: 5081-5087,2004.
23. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H and Whiteside TL: Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 82: 981-989, 2000.
24. Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, Hirakawa H, Numa F, Silverman GA and Kato H: Suppression of a squamous cell carcinoma (SCC) - related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res 61: 1776-1780, 2001.
25. Murakami A, Suminami Y, Hirakawa H, Nawata S, Numa F and Kato H: Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br J Cancer 84: 851-858, 2001.
26. McGettrick AF, Barnes RC and Worrall DM: SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells: the reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur J Biochem 268: 5868-5875,2001.
27. Tsuyama S, Hashimoto K, Nakamura K, Tamura H, Sasaki K and Kato H: Different behaviors in the production and release of SCC antigen in squamous-cell carcinoma. Tumor Biol 12: 28-34, 1991.
28. Numa F, Takeda O, Nakata M, Nawata S, Tsunaga N, Hirabayashi K, Suminami Y, Kato H and Hamanaka S: Tumor necrosis factor-a stimulates the production of squamous cell carcinoma antigen in normal squamous cells. Tumor Biol 17: 97-101,1996.
29. Katz AB and Taichman LB: A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol 112: 818-821,1999.
30. Thakker-Varia S, Elkabes S, Shick C, Silverman GA, Peng L, Sherwood AC and Black IB: Gene expression in activated brain microglia: identification of a proteinase inhibitor that increases microglial cell number. Brain Res Mol Brain Res 56: 99-107, 1998.
31. Liotta LA, Rao CN and Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 49: 636-649,1983.
32. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336,1991.
33. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23,2001.
34. Nuovo GJ, MacConnell PB, Simsir A, Valea F and French DL: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementry DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267-275,1995.
35. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, Ben-Baruch G and Reich R: Expression of matrix metalloprotease-9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 72: 380-386, 1999.
36. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Nictolis MD, and Biagini G: Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloprotease immunostaining. Gynecol Oncol 61: 197-203,1999.
37. Nair SA, Karunagaran D, Nair MB and Sudhakaran PR: Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. J Cancer Res Clin Oncol 129: 123-131,2003.
38. Sheu B-C, Lien H-C, Ho H-N, Lin H-H, Chow S-N, Hauang S-C and Hsu S-M: Increased expression and activation of gelatinolytic matrix metalloproteases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63: 6537-6542, 2003.
39. Argüello-Ramírez J, Pérez-Cárdenas E, Delgado-Chávez R, Solorza-Luna G, Villa-Treviño S and Arenas-Huertero F: Matrix metalloproteinases-2, -3 and -9 secreted by explants of benign and malignant lesions of the uterine cervix. Int J Gynecol Cancer 14: 333-340, 2004.
40. Zelvyte I, Sjögren H-O and Janciauskiene S: Effects of native and cleaved forms of α1-antitrypsin on ME 1477 tumor cell functional activity. Cancer Detect Prev 26: 256-265, 2002.
41. Zelvyte I, Lindgren S and Janciauskiene S: Multiple effects of α1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness. Eur J Cancer Prev 12: 117-124, 2003.
42. Shick C, Bromme D, Bartuski AJ, Uemura Y, Schechter NM and Silverman GA: The reactive site loop of the serpin SCCA1 is essential for cysteine protease inhibition. Proc Natl Acad Sci USA 95: 13465-13470,1998.
43. Luke C, Shick C, Tsu C, Whisstock JC, Irving JA, Brömme D, Juliano L, Shi G-P, Chapman HA and Silverman GA: Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine protease inhibitor: A critical role for the P3′ proline in facilitating RSL cleavage. Biochemistry 39: 7081-7091, 2000.
44. Heussen C and Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196-202, 1980.
45. Kato Y, Yamashita T and Ishikawa M: Relationship between expression of matrix metalloproteinase-2 and metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 9: 565-569,2002.
46. Chan Y-L, Lin A, McNally J, Peleg D, Meyuhas O and Wool IG: The primary structure of rat ribosomal protein L19: a determination from the sequence of nucleotides in a cDNA and from the sequence of amino acids in the protein. J Biol Chem 262: 1111-1115,1987.
47. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245,1987.
48. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA and Opdenakker G: Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37: 375-536,2002.
49. Bannikov GA, Karelina TV, Collier IE, Marmer BL and Goldberg GI: Substrate biding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277: 16022-16027,2002.
50. Guann M, Pang CP, Yam HF, Cheung KF, Liu WW and Lu Y: Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11: 325-332 2004.
51. Janciauskiene S: Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles Biochim Biophys Acta 1535: 221-235, 2001.
52. Patston PA, Church FC and Olson ST: Serpin-ligand interactions. Methods 32: 93-109, 2004.
53. Takeda T, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF and Hibino T: Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Invest Dermatol 118: 147-154 2002.
54. De Falco S, Ruvoletto MG, Verdoliva A, Ruvo M, Raucci A, Marino M, Senatore S, Cassani G, Alberti A, Pontisso P and Fassina G: Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 276: 36613-36623,2001.
55. Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, Sakaguchi Y, Kato H, Ito M, Yoshida K and Kudo R: El AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Exp Cell Res 299: 525-532, 2004.